Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study.

Menne, Jan; Delmas, Yahsou; Fakhouri, Fadi; Licht, Christoph; Lommelé, Åsa; Minetti, Enrico E; Provôt, François; Rondeau, Eric; Sheerin, Neil S; Wang, Jimmy; Weekers, Laurent E; Greenbaum, Larry A.
BMC Nephrol; 20(1): 125, 2019 Apr 10.
Artigo em Inglês | MEDLINE | ID: mdl-30971227

Não foram localizados documentos relacionados